Description of Organization and Business Operations (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Jan. 10, 2020 |
Mar. 04, 2019 |
Mar. 16, 2020 |
Aug. 19, 2019 |
Jun. 22, 2018 |
Apr. 30, 2018 |
Mar. 31, 2020 |
Dec. 31, 2019 |
Mar. 31, 2019 |
Dec. 31, 2018 |
|
Sale of units per share | $ 10.20 | |||||||||
Deferred underwriting commissions | $ 5,433,750 | $ 5,433,750 | ||||||||
Cash placed in a trust account | $ 162,618,769 | 162,019,909 | ||||||||
Percentage of asset held in trust account | 80.00% | |||||||||
Business combination, percentage of voting securities | 50.00% | |||||||||
Tax obligation, maximum amount | $ 100,000 | |||||||||
Business Combination, minimum amount of net tangible assets | 5,000,001 | |||||||||
Cash | 385,760 | 161,405 | $ 433,291 | $ 196,804 | ||||||
Woking capital | $ 1,200,000 | |||||||||
Working capital loan repayment description | The Working Capital Loans will either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. On March 4, 2019, the Company issued a convertible note (“Convertible Note”) to the Sponsor, pursuant to which the Sponsor agreed to provide a Working Capital Loan to the Company of up to $1.5 million. The Company was provided $750,000 and $430,000 in loan proceeds during the year ended December 31, 2019 and the three months ended March 31, 2020, respectively, for an aggregate amount of $1.18 million, pursuant to the amended Convertible Note (see Note 5). | |||||||||
Proceeds from Convertible debt | $ 130,000 | $ 300,000 | ||||||||
Convertible debt | $ 1,180,000 | |||||||||
Sponsor [Member] | ||||||||||
Working capital loan repayment description | The Sponsor had agreed to loan the Company an aggregate of up to $300,000 | |||||||||
Working Capital Loan | $ 1,500,000 | |||||||||
Proceeds from Convertible debt | $ 400,000 | $ 350,000 | $ 430,000 | $ 750,000 | ||||||
Private Placement Warrants [Member] | ||||||||||
Sale of units in initial public offering | 7,760,000 | |||||||||
Sale of units in initial public offering aggragate amount | $ 7,760,000 | |||||||||
Warrants price per share | $ 1.00 | |||||||||
Private Placement Warrants [Member] | Sponsor [Member] | ||||||||||
Sale of units in initial public offering | 7,209,560 | |||||||||
Over-Allotment Option [Member] | ||||||||||
Sale of units in initial public offering | 2,025,000 | |||||||||
Initial Public Offering [Member] | ||||||||||
Sale of units in initial public offering | 15,525,000 | |||||||||
Sale of units per share | $ 10.00 | |||||||||
Sale of units in initial public offering aggragate amount | $ 155,250,000 | |||||||||
Warrants price per share | $ 1.00 | |||||||||
Deferred underwriting commissions | $ 5,433,800 | |||||||||
Offering costs | $ 9,300,000 |